Carl P. Sherr & Co’s Biogen BIIB Stock Holding History

Carl P. Sherr & Co’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,376	Closed	-$385K	–	120
2021 Q1	$385K	Buy	1,376 +194	+16%	+$52.3K	0.29%	85
2020 Q4	$289K	Buy	1,182 +45	+4%	+$11.6K	0.23%	94
2020 Q3	$323K	Buy	+1,137	New	+$317K	0.29%	81

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Carl P. Sherr & Co's BIIB Position: Q2 2021 in Review

Carl P. Sherr & Co sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,376 shares — an estimated $385K sold.

Carl P. Sherr & Co first reported a position in BIIB in Q3 2020 and held it in 3 quarters. The position peaked at $385K in Q1 2021. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Carl P. Sherr & Co reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Carl P. Sherr & Co sold 1,376 Biogen shares in Q2 2021, an estimated $385K.
Carl P. Sherr & Co first reported a position in Biogen in Q3 2020 and held it in 3 quarters.
Carl P. Sherr & Co's Biogen position peaked at $385K in Q1 2021.
1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Carl P. Sherr & Co's 13F filing for Q2 2021, filed 21 Jul 2021.